store at low temperature
store at -80°C
Anifrolumab(MEDI-546) is a potent type I interferon (IFN) receptor antagonist, a human monoclonal antibody that targets IFN.Anifrolumab inhibits the activity of type I interferon and is used for the prevention and treatment of systemic lupus erythematosus (SLE).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 45,500 |
5 mg | 在庫あり | ¥ 102,500 |
10 mg | 在庫あり | ¥ 158,500 |
25 mg | 在庫あり | ¥ 245,500 |
50 mg | 在庫あり | ¥ 333,000 |
100 mg | 在庫あり | ¥ 447,500 |
説明 | Anifrolumab(MEDI-546) is a potent type I interferon (IFN) receptor antagonist, a human monoclonal antibody that targets IFN.Anifrolumab inhibits the activity of type I interferon and is used for the prevention and treatment of systemic lupus erythematosus (SLE). |
ターゲット&IC50 | ISRE:0.3 nM |
In vitro |
Anifrolumab induces sustained reduction of surface IFNAR1 and abrogates STAT1 phosphorylation at a concentration of 67.7 nM for 20 minutes[1]. Anifrolumab suppresses the differentiation of B cells into plasma cells at concentrations of 1 and 10 μg/mL for 6 or 7 days[1]. Anifrolumab inhibits type I IFN-induced ISRE signaling, with IC50s ranging from 0.004 to 0.3 nM for the IFN-α subtypes, and 0.03 nM and 0.07 nM for IFN-β and IFN-ω, respectively[1].At a concentration of 67.7 nM, Anifrolumab dose-dependently inhibits IFN-α production from pDCs in response to CpG-A or DNA-IC stimulation, inhibiting 87-95% of IFN-α production[1]. |
別名 | MDX-1333, MEDI-546 |
分子量 | N/A |
CAS No. | 1326232-46-5 |
store at low temperature
store at -80°C
DMSO: 60 mg/mL (144.07 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Anifrolumab 1326232-46-5 Immunology/Inflammation IFNAR MDX-1333 MDX1333 MEDI546 MDX 1333 MEDI-546 MEDI 546 Inhibitor inhibitor inhibit